Deciphering biology, discovering new classes of anti-infectives
ArrePath is a Princeton-based biotech company applying AI, machine learning, and advanced imaging technologies to discover new classes of small molecule anti-infectives targeting antimicrobial resistance. The company was spun out of Princeton University's Gitai Lab and has developed early proof-of-concept antibiotics now advancing toward clinical development.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountJun 2025
Nov 2024
Mar 2022
Create a free account to see which investors have funded this company.
Create Free AccountAI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Health insurance company using technology to make health care simple, affordable, and accessible.
Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...
